🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Several experts stated the popularity for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Material Elimination

Based on TikTok, the service has taken down problematic content and banned associated hashtags and search suggestions. The organization stated it was committed to keeping the service secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly significant medical dangers”.